On Saturday we had the opportunity to bring our science closer to the public. We talked all about future therapies for Down syndrome and Fragile X syndrome 👩🔬🧪🧬See you next year! @the_prbb#openPRBB
I am delighted to share that the second paper from my thesis carried out at @OzaitaLab, is finally out in the British Journal of Pharmacology 🎉
#Cannabinoids#Cognition
https://t.co/bzWfiBu4cJ
Really grateful and happy to be awarded with one of the best oral communications at @SEICannabinoide. It was always a pleasure to present our results here. Congrats to all the others awarded!! @OzaitaLab@UPFbiomed
SEROTONERGIC MECHANISM IS INVOLVED IN THE PROCOGNITIVE EFFECT OF CB1R PERIPHERAL INHIBITION IN A MOUSE MODEL OF FRAGILE X SYNDROME de los Reyes-Ramírez L
On Tuesday Lucía de los Reyes Ramírez @lu_delos successfully defended her Doctoral Thesis. Congratulatios Dr. De los Reyes-Ramirez! 🎉🎓 @UPFbiomed@the_prbb @upfbar
First FraXI Congress: Day 2
Working together and learning from each other's experiences, embracing all the new goals to achieve. Thanks to all the speakers and family delegates from around the world.
https://t.co/deXWM4ilA5
#FraXIcongress#barcelona2024
Today, on World Fragile X Day, we show support for the people affected by this condition. In @OzaitaLab we are committed to Fragile X Syndrome research with several ongoing projects #fragileXsyndrome#fragileXawareness
Feeling incredible grateful to @EduEyras and his lab for the amazing three months that I spent at @JCSMR. I had a wonderful experience and learned so much there. Thanks for everything 🖥️🧠🧬
Lucía de los Reyes has just presented the work about "Peripheral CB1R inhibition ameliorates cognitive and molecular alterations of a mouse model of fragile X syndrome" Excellent work Lucía! 👏 #SEIC2023
First comes from Lucía de los Reyes (@lu_delos) from
@OzaitaLab presenting her work 'Behavioral and molecular outcomes of targeting CB1 receptor in a mouse model of intellectual disability' 🧠🐀#MELISymposium
We are delighted to share our new publised article in eLife (@eLife) titled “Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams–Beuren syndrome”
Link to full article:https://t.co/SV3hKQLzi4
We are glad to share our new article published in Neuropsychopharmacology entitled: "Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism"
Congratulations to all the authors!
Link to the article: https://t.co/bziW6caUhU